Exosomes: the future of biomarkers in medicine

Biomarkers in Medicine

Volumn 7, Issue 5, 2013, Pages 769-778

  Properzi, Francesca ^a   Logozzi, Mariantonia ^a   Fais, Stefano ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

biomarkers; exosomes; nanotheranostics; nanovesicles; neurodegenerative diseases; prion diseases; tumor diagnosis

Indexed keywords

ALPHA SYNUCLEIN; BIOLOGICAL MARKER; CAVEOLIN 1; CD63 ANTIGEN; CYCLIC AMP DEPENDENT TRANSCRIPTION FACTOR 3; FETUIN A; LACTATE DEHYDROGENASE; MICRORNA; PRION PROTEIN; TRANSCRIPTION FACTOR 3; UNCLASSIFIED DRUG; WT1 PROTEIN;

BARTTER SYNDROME; CANCER CELL CULTURE; CANCER ELISA KIT; CANCER SCREENING; DEGENERATIVE DISEASE; DIAGNOSTIC EQUIPMENT; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; EXOSOME; FLOW CYTOMETRY; GASTROENTERITIS; HUMAN; KIDNEY DISEASE; NONHUMAN; PRION DISEASE; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TUMOR DIAGNOSIS; WESTERN BLOTTING;

ANIMALS; BIOLOGICAL MARKERS; EXOSOMES; HUMANS; MEDICINE; NEOPLASMS; NEURODEGENERATIVE DISEASES; PRIONS;

EID: 84884585784     PISSN: 17520363     EISSN: 17520371     Source Type: Journal    
DOI: 10.2217/bmm.13.63     Document Type: Review

References (88)

1. Théry C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 9(8), 581-593 (2009
2. Huotari J, Helenius A. Endosome maturation. EMBO J. 30(17), 3481-3500 (2011
3. Bobrie A, Colombo M, Raposo G, Théry C. Exosome secretion: Molecular mechanisms and roles in immune responses. Traffic 12(12), 1659-1668 (2011
4. van der Pol E, Böing AN, Harrison P, Sturk A, Nieuwland R. Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol. Rev. 64(3), 676-705 (2012
5. Heijnen HF, Schiel AE, Fijnheer R, Geuze HJ, Sixma JJ. Activated platelets release two types of membrane vesicles: Microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and a-granules. Blood 94(11), 3791-3799 (1999
6. Johnstone RM, Bianchini A, Teng K. Reticulocyte maturation and exosome release: Transferrin receptor containing exosomes shows multiple plasma membrane functions. Blood 74(5), 1844-1851 (1989
7. Johnstone RM. Exosomes biological significance: A concise review. Blood Cells Mol. Dis. 36(2), 315-321 (2006
8. Muntasell A, Berger AC, Roche PA. T cell-induced secretion of MHC class II-peptide complexes on B cell exosomes. EMBO J. 26(19), 4263-4272 (2007
9. Quah BJ, O'Neill HC. The immunogenicity of dendritic cell-derived exosomes. Blood Cells Mol. Dis. 35(2), 94-110 (2005
10. Simpson RJ, Lim JW, Moritz RL, Mathivanan S. Exosomes: Proteomic insights and diagnostic potential. Expert Rev. Proteomics 6(3), 267-283 (2009
11. Zitvogel L, Regnault A, Lozier A et al. Eradication of established murine tumors using a novel cell-free vaccine: Dendritic cell-derived exosomes. Nat. Med. 4(5), 594-600 (1998
12. Viaud S, Théry C, Ploix S et al. Dendritic cell-derived exosomes for cancer immunotherapy: What's next? Cancer Res. 70(4), 1281-1285 (2010
13. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell. Biol. 9(6), 654-659 (2007
14. Lotvall J, Valadi H. Cell to cell signalling via exosomes through esRNA. Cell Adh. Migr. 1(3), 156-158 (2007
15. Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, Ochiya T. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J. Biol. Chem. 285(23), 17442-17452 (2010
16. Simpson RJ, Jensen SS, Lim JW. Proteomic profiling of exosomes: Current perspectives. Proteomics 8(19), 4083-4099 (2008
17. Street JM, Birkhoff W, Menzies RI, Webb DJ, Bailey MA, Dear JW. Exosomal transmission of functional aquaporin 2 in kidney cortical collecting duct cells. J. Physiol. (Lond.) 589(Pt 24), 6119-6127 (2011
18. Nilsson J, Skog J, Nordstrand A et al. Prostate cancer-derived urine exosomes: A novel approach to biomarkers for prostate cancer. Br. J. Cancer 100(10), 1603-1607 (2009
19. Takata K, Matsuzaki T, Tajika Y, Ablimit A, Hasegawa T. Localization and trafficking of aquaporin 2 in the kidney. Histochem. Cell. Biol. 130(2), 197-209 (2008
20. Sonoda H, Yokota-Ikeda N, Oshikawa S et al. Decreased abundance of urinary exosomal aquaporin-1 in renal ischemia-reperfusion injury. Am. J. Physiol. Renal Physiol. 297(4), F1006-F1016 (2009
21. Looze C, Yui D, Leung L et al. Proteomic profiling of human plasma exosomes identifies PPARg as an exosome-associated protein. Biochem. Biophys. Res. Commun. 378(3), 433-438 (2009
22. Logozzi M, De Milito A, Lugini L et al. High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PLoS ONE 4(4), e5219 (2009
23. Rabinowits G, Gerçel-Taylor C, Day JM, Taylor DD, Kloecker GH. Exosomal microRNA: A diagnostic marker for lung cancer. Clin. Lung Cancer 10(1), 42-46 (2009
24. Michael A, Bajracharya S, Yuen P et al. Exosomes from human saliva as a source of microRNA biomarkers. Oral Dis. 16(1), 34-38 (2010
25. Palanisamy V, Sharma S, Deshpande A, Zhou H, Gimzewski J, Wong DT. Nanostructural and transcriptomic analyses of human saliva derived exosomes. PLoS ONE 5(1), e8577 (2010
26. Keller S, Rupp C, Stoeck A et al. CD24 is a marker of exosomes secreted into urine and amniotic fluid. Kidney Int. 72(9), 1095-1102 (2007
27. Mathivanan S, Ji H, Simpson RJ. Exosomes: Extracellular organelles important in intercellular communication. J. Proteomics 73(10), 1907-1920 (2010
28. Mathivanan S, Lim JWE, Tauro BJ, Ji H, Moritz RL, Simpson RJ. Proteomics analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature. Mol. Cell. Proteomics 9(2), 197-208 (2010
29. Coren LV, Shatzer T, Ott DE. CD45 immunoaffinity depletion of vesicles from Jurkat T cells demonstrates that exosomes contain CD45: No evidence for a distinct exosome/HIV-1 budding pathway. Retrovirology 5, 64 (2008
30. Keller S, König AK, Marmé F et al. Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes. Cancer Lett. 278(1), 73-81 (2009
31. Mitchell PJ, Welton J, Staffurth J et al. Can urinary exosomes act as treatment response markers in prostate cancer? J. Transl. Med. 7, 4 (2009
32. Lu Q, Zhang J, Allison R et al. Identification of extracellular d-catenin accumulation for prostate cancer detection. Prostate 69(4), 411-418 (2009
33. Smalley DM, Sheman NE, Nelson K, Theodorescu D. Isolation and identification of potential urinary microparticle biomarkers of bladder cancer. J. Proteome Res. 7(5), 2088-2096 (2008
34. Keller S, Ridinger J, Rupp AK, Janssen JWG, Altevogt P. Body fluid derived exosomes as a novel template for clinical diagnostics. J. Transl. Med. 9, 86 (2011
35. Skog J, Würdinger T, Van Rijn S et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell. Biol. 10(12), 1470-1476 (2008
36. Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol. Oncol. 110(1), 13-21 (2008
37. Rabinowits G, Gerçel-Taylor C, Day JM, Taylor DD, Kloecker GH. Exosomal microRNA: A diagnostic marker for lung cancer. Clin. Lung Cancer 10(1), 42-46 (2009
38. Gomes C, Keller S, Altevogt P, Costa J. Evidence for secretion of Cu, Zn superoxide dismutase via exosomes from a cell model of amyotrophic lateral sclerosis. Neurosci. Lett. 428(1), 43-46 (2007
39. Emmanouilidou E, Melachroinou K, Roumeliotis T et al. Cell-produced a-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J. Neurosci. 30(20), 6838-6851 (2010
40. Rajendran L, Honsho M, Zahn TR et al. Alzheimer's disease b-amyloid peptides are released in association with exosomes. Proc. Natl Acad. Sci. USA 103(30), 11172-11177 (2006
41. Saman S, Kim W, Raya M et al. Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease. J. Biol. Chem. 287(6), 3842-3849 (2012
42. Goedert M, Clavaguera F, Tolnay M. The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci. 33(7), 317-325 (2010
43. Alvarez-Erviti L, Seow Y, Schapira AH et al. Lysosomal dysfunction increases exosome-mediated a-synuclein release and transmission. Neurobiol. Dis. 42(3), 360-367 (2011
44. Danzer KM, Kranich LR, Ruf WP et al. Exosomal cell-to-cell transmission of a synuclein oligomers. Mol. Neurodegener. 7, 42 (2012
45. Surgucheva I, Sharov VS, Surguchov A. g-synuclein: Seeding of a-synuclein aggregation and transmission between cells. Biochemistry 51(23), 4743-4754 (2012
46. Tasaki M, Ueda M, Ochiai S et al. Transmission of circulating cell-free AA amyloid oligomers in exosomes vectors via a prion-like mechanism. Biochem. Biophys. Res. Commun. 400(4), 559-562 (2010
47. De Smaele E, Ferretti E, Gulino A. MicroRNAs as biomarkers for CNS cancer and other disorders. Brain Res. 1338, 100-111 (2010
48. Williams AH, Valdez G, Moresi V et al. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 326(5959), 1549-1554 (2009
49. Soto C. Diagnosing prion diseases: Needs, challenges and hopes. Nat. Rev. Microbiol. 2(10), 809-819 (2004
50. Aguzzi A, Glatzel M. Prion infections, blood and transfusions. Nat. Clin. Pract. Neurol. 2(6), 321-329 (2006
51. Houston F, McCutcheon S, Goldmann W et al. Prion diseases are efficiently transmitted by blood transfusion in sheep. Blood 112(12), 4739-4745 (2008
52. Morales R, Duran-Aniotz C, Diaz-Espinoza R, Camacho MV, Soto C. Protein misfolding cyclic amplification of infectious prions. Nat. Protoc. 7(7), 1397-1409 (2012
53. McGuire LI, Peden AH, Orrú CD et al. Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease. Ann. Neurol. 72(2), 278-285 (2012
54. Edgeworth JA, Farmer M, Sicilia A et al. Detection of prion infection in variant Creutzfeldt-Jakob disease: A blood-based assay. Lancet 377(9764), 487-493 (2011
55. Fevrier B, Vilette D, Archer F et al. Cells release prions in association with exosomes. Proc. Natl Acad. Sci. USA 101(26), 9683-9688 (2004
56. Alais S, Simoes S, Baas D et al. Mouse neuroblastoma cells release prion infectivity associated with exosomal vesicles. Biol. Cell 100(10), 603-615 (2008
57. Leblanc P, Alais S, Porto-Carreiro I et al. Retrovirus infection strongly enhances scrapie infectivity release in cell culture. EMBO J. 25(12), 2674-2685 (2006
58. Castro-Seoane R, Hummerich H, Sweeting T et al. Plasmacytoid dendritic cells sequester high prion titres at early stages of prion infection. PLoS Pathog. 8(2), e1002538 (2012
59. Robertson C, Booth SA, Beniac DR, Coulthart MB, Booth TF, McNicol A. Cellular prion protein is released on exosomes from activated platelets. Blood 107(10), 3907-3911 (2006
60. Jones M, Peden AH, Yull H et al. Human platelets as a substrate source for the in vitro amplification of the abnormal prion protein (PrP) associated with variant Creutzfeldt-Jakob disease. Transfusion 49(2), 376-384 (2009
61. Wang GH, Zhou XM, Bai Y, Yin XM, Yang LF, Zhao D. Hsp70 binds to PrPC in the process of PrPC release via exosomes from THP-1 monocytes. Cell Biol. Int. 35(6), 553-558 (2011
62. Fauré J, Lachenal G, Court M et al. Exosomes are released by cultured cortical neurones. Mol. Cell. Neurosci. 31(4), 642-648 (2006
63. Taylor DR, Hooper NM. The prion protein and lipid rafts. Mol. Membr. Biol. 23(1), 89-99 (2006
64. Lasmézas CI, Deslys JP, Robain O et al. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 275(5298), 402-405 (1997
65. Barron RM, Campbell SL, King D et al. High titers of transmissible spongiform encephalopathy infectivity associated with extremely low levels of PrPSc in vivo. J. Biol. Chem. 282(49), 35878-35886 (2007
66. Piccardo P, Manson JC, King D, Ghetti B, Barron RM. Accumulation of prion protein in the brain that is not associated with transmissible disease. Proc. Natl Acad. Sci. USA 104(11), 4712-4717 (2007
67. Saba R, Goodman CD, Huzarewich RL, Robertson C, Booth SA. A miRNA signature of prion induced neurodegeneration. PLoS ONE 3(11), e3652 (2008
68. Montag J, Hitt R, Opitz L, Schulz-Schaeffer WJ, Hunsmann G, Motzkus D. Upregulation of miRNA hsa-miR 342-3p in experimental and idiopathic prion disease. Mol. Neurodegener. 4, 36 (2009
69. Bellingham SA, Coleman BM, Hill AF. Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cells. Nucleic Acids Res. 40(21), 10937-10949 (2012
70. Izquierdo-Useros N, Puertas MC, Borràs FE, Blanco J, Martinez-Picado J. Exosomes and retroviruses: The chicken or the egg? Cell. Microbiol. 13(1), 10-17 (2011
71. Izquierdo-Useros N, Naranjo-Gómez M, Archer J et al. Capture and transfer of HIV-1 particles by mature dendritic cells converges with the exosome-dissemination pathway. Blood 113(12), 2732-2741 (2009
72. De Gassart A, Trentin B, Martin M et al. Exosomal sorting of the cytoplasmic domain of bovine leukemia virus TM Env protein. Cell. Biol. Int. 33(1), 36-48 (2009
73. Gan X, Gould SJ. Identification of an inhibitory budding signal that blocks the release of HIV particles and exosome/microvesicle proteins. Mol. Biol. Cell 22(6), 817-830 (2011
74. Pegtel DM, Cosmopoulos K, Thorley-Lawson DA et al. Functional delivery of viral miRNAs via exosomes. Proc. Natl Acad. Sci. USA 107(14), 6328-6333 (2010
75. Barreto A, Rodríguez LS, Rojas OL et al. Membrane vesicles released by intestinal epithelial cells infected with rotavirus inhibit T-cell function. Viral Immunol. 23(6), 595-608 (2010
76. Gould SJ, Booth AM, Hildreth JEK. The trojan exosome hypothesis. Proc. Natl Acad. Sci. USA 100(19), 10592-10597 (2003
77. Zhou H, Pisitkun T, Aponte A et al. Exosomal Fetuin-A identified by proteomics: A novel urinary biomarker for detecting acute kidney injury. Kidney Int. 70(10), 1847-1857 (2006
78. Gonzales PA, Pisitkun T, Hoffert JD et al. Large-scale proteomics and phosphoproteomics of urinary exosomes. J. Am. Soc. Nephrol. 20(2), 363-379 (2009
79. Zhuang X, Xiang X, Grizzle W et al. Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol. Ther. 19(10), 1769-1779 (2011
80. Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJA. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol. 29(4), 341-345 (2011
81. Hood JL, Wickline SA. A systematic approach to exosome-based translational nanomedicine. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 4(4), 458-467 (2012
82. Vlassov AV, Magdaleno S, Setterquist R, Conrad R. Exosomes: Current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim. Biophys. Acta 1820(7), 940-948 (2012
83. van Dommelen SM, Vader P, Lakhal S et al. Microvesicles and exosomes: Opportunities for cell-derived membrane vesicles in drug delivery. J. Control. Release 161(2), 635-644 (2012
84. Rood IM, Deegens JK, Merchant ML et al. Comparison of three methods for isolation of urinary microvesicles to identify biomarkers of nephrotic syndrome. Kidney Int. 78(8), 810-816 (2010
85. Wittmann J, Jäck HM. Serum microRNAs as powerful cancer biomarkers. Biochim. Biophys. Acta 1806(2), 200-207 (2010
86. Corcoran C, Friel AM, Duffy MJ, Crown J, O'Driscoll L. Intracellular and extracellular microRNAs in breast cancer. Clin. Chem. 57(1), 18-32 (2011
87. Li J, Sherman-Baust CA, Tsai-Turton M, Bristow RE, Roden RB, Morin PJ. Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer. BMC Cancer 9, 244 (2009
88. Bala S, Petrasek J, Mundkur S et al. Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases. Hepatology 56(5), 1946-1957 (2012